Rheumatoid arthritis

Rheumatoid arthritis is a chronic inflammatory disease that primarily affects the joints, although it can also compromise other organs. There is definitely a genetic component, but its cause is unknown.

It principally manifests as pain and inflammation in the joints (hands, feet, shoulders, knees, etc.) and morning stiffness. It can be accompanied by fever, general malaise, and/or fatigue. 

Untreated rheumatoid arthritis can end up causing a deterioration and deformity of the affected joints, which can cause serious disabilities. However, the early diagnosis we often perform and the quantity of drugs we have available today mean that most patients with rheumatoid arthritis can lead a practically normal life. For rheumatoid arthritis to have a good clinical evolution, an early diagnosis is very important, starting treatment as soon as possible. This is because the first years during which the illness presents are key for improving the prognosis and evolution of these patients.

Authorship: Helena Borrell Paños
Creation date: 14.03.2022, 08:47
Modification date: 01.12.2022, 10:29
Share it
Did you find this helpful?

Contingut relacionat

Notícies relacionades

Subscribe to our newsletters and be a part of Campus Life

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vhebron.net, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.